By Christy Santhosh Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up ...

Formation Bio and Jiangsu Chia Tai Feng Hai Pharmaceutical Co., LTD. (CTFH) today announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to FHND5032, an oral, ...

Eli Lilly signs major deals with Repertoire Immune and Seamless Therapeutics, committing billions to autoimmune disease ...

Biogen BIIB announced that the FDA has granted the Breakthrough Therapy designation to its investigational, first-in-class, ...

As part of the deal, Repertoire Immune Medicines will develop up to three drug candidates that target the drivers of certain autoimmune diseases.

Scientists at the University of Virginia say they may be one step closer to stopping a rare and deadly disease that hardens ...

Repertoire Immune Medicines partners with Eli Lilly to develop tolerizing therapies for autoimmune diseases, receiving $85 ...

Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. What are called autoimmune diseases can ...

Autoimmune neurological diseases are conditions where the immune system attacks nerve cells. Damage to neuronal cells can lead to a variety of neurologic and psychiatric symptoms. Autoimmune diseases ...

Immune system disorders in children include primary (inherited) and secondary (acquired) immunodeficiencies, autoimmune diseases, atopic diseases, and immune-mediated inflammatory disorders. Share on ...

A relatively new class of autoimmune diseases that affect the brain is making psychiatrists rethink some diagnoses.

Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up to $1.93 billion to develop therapies for multiple autoimmune diseases, the Massachusetts-based ...